Volume 14 Supplement 1
Abstracts from the Combined Northern and Yorkshire Deaneries Rheumatology Annual Conference 2012
Meeting abstracts
Edited by Wan-Fai Ng and Jennifer Hamilton
Publication charges for supplement were met by the conference organizers with financial support from an unrestricted educational grant from Pfizer.
Northern and Yorkshire Deaneries Annual Rheumatology Conference.
York, UK26 September 2012
-
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A1
-
Soluble molecule profiling and network analysis of primary Sjögren's Syndrome patient serum
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A2 -
Bone marker reference range study: a comparison of the manufacturer’s reference range and laboratory healthy volunteer results to patients with rheumatoid arthritis
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A3 -
Unusual cause of hip pain
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A4 -
Does the key to treat Rheumatoid nodules lie with oncology? - Is Cisplatin an option?
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A5 -
Diffuse pigmented villonodular synovitis in a child – what is the best management?
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A6 -
Imaging of psoriatic nail disease pre and post anti-TNF therapy shows persistent subclinical inflammation despite good clinical response
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A7 -
Acute polymyositis associated with hemophagocytic lymphohistiocytosis syndrome
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A8 -
Refractory multisystem sarcoidosis involving pelvic bone responding to infliximab
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A9 -
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A10 -
Granulomatosis with polyangitis presenting with multiple cranial nerve palsies
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A11 -
Are admissions for gout preventable? An audit
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A12 -
Rheumatologists’ ultrasound confidence and technique are improved by a two day cadaveric sonoanatomy course
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A13 -
New patients to the Leeds spondyloarthritis clinic: is referral stratification working?
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A14 -
Assessment of blood clot formation in patients with Primary Sjögren’s syndrome (pSS)
Citation: BMC Musculoskeletal Disorders 2013 14(Suppl 1):A15
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.2
5-year Journal Impact Factor: 2.6
Source Normalized Impact per Paper (SNIP): 1.086
SCImago Journal Rank (SJR): 0.714
Speed 2023
Submission to first editorial decision (median days): 24
Submission to acceptance (median days): 143
Usage 2023
Downloads: 5,883,887
Altmetric mentions: 5,748Transparency and Openess
TOP Factor Score - 8
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication
Follow
Research Data Helpdesk
Authors can receive free advice on how and where to share their research data, according to their specific research community from a team of research data editors.